Skip to content
value.today

AbbVie Inc. vs Brain+ A/S

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • AbbVie Inc. is the larger company by market value: $514.0 B against $1 M for Brain+ A/S, 514005 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for Brain+ A/S). Brain+ A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Market value, the same start = 100

From Dec 2022: how each one's value moved, whatever its size.

045891341782023202420252026AbbVie Inc. 178Brain+ A/S 25

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$15B$31B$46B$61B201720182019202020212022202320242025AbbVie Inc. $61B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureAbbVie Inc.
ABBV · #26 in the world
Brain+ A/S
BRAINP.CO
Profile
Country🇺🇸 USA🇩🇰 Denmark
SectorHealthcareHealthcare
IndustryPharmaceutical—
Founded2013—
Size
Market cap$514.0 B$1 M*
Revenue$61.2 B—
Net income$4.2 B—
Employees57,000—
Valuation
P/E ratio49.7×—
Price to sales7.8×—
Free cash flow yield3.5%—
Profitability
Gross margin70.2%—
Operating margin24.6%—
Net margin6.9%—
Return on invested capital16.0%—
Growth
Revenue growth8.6%—
Revenue growth, 3 years a year1.8%—
Earnings per share growth-1.3%—
Financial strength
Interest cover5.2×—
Cash
Free cash flow margin29.1%—
Shareholder returns
Dividend yield2.3%—
Shareholder yield2.5%—
Strength scores
Piotroski F-score8 of 9—
Altman Z-score zonegrey—
Data as ofMarket cap Oct 2026; ratios FY2025Market cap Jan 2024

▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither

Questions and answers#

Which is bigger, AbbVie Inc. or Brain+ A/S?

AbbVie Inc. is the larger company by market value: $514.0 B against $1 M for Brain+ A/S, 514005 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 5, 2024 for Brain+ A/S). Brain+ A/S's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.

Sources#

Every figure on this page comes from these, with the date shown next to it.